Commentary: Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment - A quasi-randomized retrospective study.

Ashish A Ahuja, Chitaranjan Mishra
Author Information
  1. Ashish A Ahuja: Vitreo Retina Consultant at Sadhu Kamal Eye Hospital, Mumbai, Maharashtra, India.
  2. Chitaranjan Mishra: Department of Vitreo-Retina, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Abstract

No abstract text available.

References

  1. J Ophthalmic Vis Res. 2016 Jan-Mar;11(1):93-9 [PMID: 27195092]
  2. Int J Retina Vitreous. 2020 Jan 14;6:2 [PMID: 31956432]
  3. Surv Ophthalmol. 2019 Nov - Dec;64(6):780-809 [PMID: 31077688]
  4. Ophthalmology. 1989 Oct;96(10):1501-10 [PMID: 2587045]
  5. Indian J Ophthalmol. 2021 Nov;69(11):3283-3287 [PMID: 34708788]
  6. Pharmaceutics. 2019 Jul 31;11(8): [PMID: 31370346]
  7. BMJ Open Ophthalmol. 2019 Dec 10;4(1):e000390 [PMID: 31909195]
  8. Int J Retina Vitreous. 2021 Apr 26;7(1):35 [PMID: 33902755]

MeSH Term

Bevacizumab
Diabetes Mellitus
Humans
Retinal Detachment
Retrospective Studies
Vitrectomy
Vitreous Hemorrhage

Chemicals

Bevacizumab

Word Cloud

Created with Highcharts 10.0.0Commentary:Outcomespreoperativebevacizumabdiabeticsnonclearingvitreoushemorrhagewithouttractionaldetachment-quasi-randomizedretrospectivestudy

Similar Articles

Cited By

No available data.